A New Era in Obesity Care: Oral and Injectable GLP-1 Drugs Near Approval
If you follow weight-loss medicine, 2026 could mark a major turning point. Three new obesity drugs are nearing FDA…
-
-
Navigating Divergent Outcomes in Metabolic Approaches to Alzheimer’s Disease
Clinical investigations into GLP-1 receptor agonists for neurodegeneration recently yielded conflicting results that challenge current medical assumptions. To be…
-
New Weight-Loss Pill Offers Hope, Convenience for Millions in Wisconsin
A new weight-loss pill is poised to change obesity treatment in the United States. The first oral GLP-1 medication…
-
Oral Wegovy’s Unique Bottle Sparks Discussion as Experts Explain Its Purpose
A distinctive packaging design in the recently released oral Wegovy weight-loss medication has drawn attention from patients and online…
-
Clinical Contraindications and Precautions for Oral GLP-1 Receptor Agonists
The landscape of metabolic medicine has undergone a paradigm shift over the last decade. As a clinician operating within…
-
The Rise of GLP-1 Pills: Results, Risks, and Reality
For years, the gold standard of medical weight loss has been synonymous with “the needle.” From the early days…
-
Beyond the Needle: BoomRx Brings Oral GLP-1 Options to Weight Management
BoomRx is pushing the weight-management market in a new direction by expanding access to oral semaglutide and tirzepatide through…
-
Dosing: How to Take GLP-1 Pills
GLP-1 pills are taken daily on an empty stomach with defined timing rules. They currently refer only to oral…
-
Wegovy Pills vs Injections: Which Is Better?
GLP-1 pills and injections both work for weight loss and blood sugar control, but they suit different people and…
-
Are There Tirzepatide Pills Yet?
Tirzepatide is not Accessible as a pill in the United States. The drug is only FDA-approved as a once-weekly…
